References
- AbelsonPHMedicine from plantsScience19902475132300807
- FujiKNodeMSaiMFujitaETakedaSUnemiNTerpenoids. LIII. Antitumor activity of trichorabdals and related compoundsChem Pharm Bull (Tokyo)198937147214762776235
- HanQBLiMLLiSHMouSHLinZWSunHDEnt-kaurane diterpenoids from Isodon rubescens var. lushanensisChem Pharm Bull (Tokyo)20035179079312843583
- IkezoeTChenSSTongXJHeberDTaguchiHKoefflerHPOridonin induces growth inhibition and apoptosis of a variety of human cancer cellsInt J Oncol2003231187119312964003
- LiCYWangEQChengYBaoJKOridonin: an active diterpenoid targeting cell cycle arrest, apoptotic and autophagic pathways for cancer therapeuticsInt J Biochem Cell Biol20114370170421295154
- ChenSGaoJHalickaHDHuangXTraganosFDarzynkiewiczZThe cytostatic and cytotoxic effects of oridonin (Rubescenin), a diterpenoid from Rabdosia rubescens, on tumor cells of different lineageInt J Oncol20052657958815703811
- JinHYTanXZLiuXFDingYJDownregulation of AP-1 gene expression is an initial event in the oridonin-mediated inhibition of colorectal cancer: studies in vitro and in vivoJ Gastroenterol Hepatol20112670671521418301
- MüllerMWFriessHKöningerJFactors influencing survival after bypass procedures in patients with advanced pancreatic adenocarcinomasAm J Surg200819522122818154768
- WrayCJAhmadSAMatthewsJBLowyAMSurgery for pancreatic cancer: recent controversies and current practiceGastroenterology20051281626164115887155
- RabinowBENanosuspensions in drug deliveryNat Rev Drug Discov2004378579615340388
- PatravaleVBDateAAKulkarniRMNanosuspensions: a promising drug delivery strategyJ Pharm Pharmacol20045682784015233860
- KesisoglouFPanmaiSWuYHNanosizing-oral formulation development and biopharmaceutical evaluationAdv Drug Deliv Rev20075963164417601629
- GaoLZhangDChenMZhengTWangSPreparation and characterization of an oridonin nanosuspension for solubility and dissolution velocity enhancementDrug Dev Ind Pharm2007331332133918097807
- LouHYZhangXMGaoLIn vitro and in vivo antitumor activity of oridonin nanosuspensionInt J Pharm200937918118619563872
- GaoLZhangDRChenMHStudies on pharmacokinetics and tissue distribution of oridonin nanosuspensionInt J Pharm200835532132718242896
- StormGBelliotSODaemenTLasicDDSurface medication of nanoparticles to oppose uptake by the mononuclear phagocyte systemAdv Drug Deliv Rev1995173148
- KirkinVJoosSZörnigMThe role of Bcl-2 family members in tumorigenesisBiochim Biophys Acta2004164422924914996506
- YinCKnudsonCMKorsmeyerSJVan DykeTBax suppresses tumorigenesis and stimulates apoptosis in vivoNature19973856376409024662
- NicholsonDWAliAThornberryNAIdentification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosisNature199537637437596430
- DenaultJBSalvesenGSCaspases: keys in the ignition of cell deathChem Rev20021024489450012475198
- PhilchenkovAACaspases as regulators of apoptosis and other cell functionsBiochemistry (Mosc)20036836537612765517
- ZouHLiYLiuXWangXAn APAF-1·Cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9J Biol Chem1999274115491155610206961
- SleeEAHarteMTKluckRMOrdering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent mannerJ Cell Biol19991442812929922454
- LiversidgeGGCundyKCParticle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogsInt J Pharm19951259197
- LiversidgeGGConzentinoPDrug particle size reduction for decreasing gastric irritancy and enhancing absorption of naproxen in ratsInt J Pharm1995125309313
- BloomJCrossFRMultiple levels of cyclin specificity in cell-cycle controlNat Rev Mol Cell Biol2007814916017245415
- HanYHKimSZKimSHParkWHArsenic trioxide inhibits the growth of Calu-6 cells via inducing a G2 arrest of the cell cycle and apoptosis accompanied with the depletion of GSHCancer Lett2008270405518539383
- ChengYQiuFYeYCTashiroSOnoderaSIkejimaTOridonin induces G2/M arrest and apoptosis via activating ERK-p53 apoptotic pathway and inhibiting PTK-Ras-Raf-JNK survival pathway in murine fibrosarcoma L929 cellsArch Biochem Biophys2009490707519699177